Professional Documents
Culture Documents
BMS2 K5 Kuliah Nyeri Kepala 2020
BMS2 K5 Kuliah Nyeri Kepala 2020
Consultant neurologist
Head, Department of Neurology
Universitas Sumatera Utara
Medan, 2022
Headache =Sefalgia
= Nyeri kepala
Definition:
pain / unpleasant sensation of the head as long as
chin until cervicooccipital
epidemiology
prevalence “life time” of headache are 90%
male and 96% female
• Migraine
– 6 - 9% man, 15-18% woman.
– Young adult age
– Genetic factor 70%
PREVALENCE MIGRAINE
female male
Epidemiology in Indonesia
(hospital base)
• Prevalence life time TTH 78%
• Episodic TTH 63% → male 56% ,female 71%
• TTH chronic 3% →male 2 % ,female 5%
–ETTH(Indonesia 31%, Medan 9.8%)
–CTTH (Indonesia 24%, Medan 44%)
• Migraine =10% (Indonesia)
–Without aura( Medan 6.3%)
–with aura (Medan 1.8%)
Prevalence in Indonesia (2004)
outpatient clinic
Appendix
Appendix
International Classification of Headache
Disorder (ICHD-3 beta version) 2013
ICHD-3 beta version Classification of MIGRAINE 2013
3. CHIRONIC MIGRAINE
4. COMPLICATIONS OF MGRAINE
5. PROBABLE MiGRAINE
1. Aura :visual,sensoris,speech,5’- 1 hr
2. At least 2 attack, 4- 72 hours
3. Unilateral
4. Throbbing
5. Moderate/severe intensity
6. Nausea/vomiting or/and
7. Phonopobia/photopobia
8. Without motor weakness
Familial Hemiplegic Migraine
• Genetik, chromosome 1 & 19
• Headache fulfilling criteria migraine with
typical aura
• Aura hemiparese →60 mnts
• Cerebellar ataxia (20%)
• Onset suddenly
• 60% patients FHM have symptom of basilar
type
Sporadic hemiplegic migraine
• criteria idem FHM
• No family history
• Normal CT Scan & EEG
Basilar type migraine
• Sign & symptoms of fossa posterior disorders
• Disartria,
• Vertigo
• Tinnitus, deafness
• Diplopia
• Ataxia
• Bilateral parestesia
• unconciousness
• Headache fulfilling criteria migraine without aura
Retinal migraine
• Rare
• At least 2 attacks scintillating, scotoma,
blindness
• Unilateral (only one eye)
• Follows with migraine with aura
• No attributed to another disorders
1.3. Chronic migraine
» Migraine without aura
» > 15 days
» > 3 months
» No attributed to another disorders
» without Medication over used
1.4 Complications of migraine
– 1.4.1 Status migrainosus
» Severe headache migraine > 72 jam
» No attributed to another disorders
– 1.4.2 Persistent aura without infarction
– 1.4.3 Migrainous infarction
– 1.4.4 Migraine-triggered seizures
1.6 Episodic syndromes that may be associated
with migraine
– 1.6.1.1 Cyclical vomiting
» 2.5% schoolchildren
» Recurrent unexplained nausea & vomiting→ 4x /hours → 5
days
» No sign of gastrointestinal disease
– 1.6.1.2 Abdominal migraine
» 12% of schoolchildren
» Abdominal pain, anorexia, nausea, vomiting
– 1.6.2 Benign paroxysmal vertigo
» At least 5 attacks severe vertigo
» Resolve within few minutes-hour
» no neurological deficit
» Normal vestibular function
» EEG normal
The triggers or precipitants of the acute migraine attack.
1207 pts migraine of whom 75.9% reported triggers.
41
summary for treatment of acute attacks
of migraine
• Triptans (serotonin1B/1D receptor agonists)
• Sumatriptan
• nasal spray evidence A 5-10 mg nasal spray
• Sumatriptan SC A 6 mg SC
• Oral triptans
• Naratriptan A 1-2.5 mg po
• Rizatriptan A 10 mg po
• Sumatriptan A 50mg po
• Zolmitriptan A 2.5-5 mg po
• DHE nasal spray A 0.5 nasal spray
• Antiemetic : Prochlorperazine B , Metoclopramide B
Preventive treatment migraine
• Antidepressant:
• Sedating : amitriptilin, doxepin, imipramin, trazodone
• Non sedating: fluoxetine, sertraline, bupropion
• Antianxiety:
• benzodiazepin,: buspiron, lorazepam, alprazolam, diazepam
Therapy TTH : non pharmacology
• Avoid the triggers
• Avoid daily usage of analgetic, sedative
• Physical Therapy :
• Masage, manual therapy, compress, traction, acupuncture,
transcutaneous electrical nerve stimulation (TENS), anaestesi
injection at trigger point, improved sleep positioning with
orthopedic pillows
• Therapy behaviour:
• Biofeedback, stress management therapy, conseling,
relaxation therapy, cognitive behaviour th/
EFNS guidelines on the treatment of cluster headache and other
trigeminal-autonomic cephalalgias.
= Temporal arteritis
= Giant cell arteritis (GCA)
• Is a systemic inflammatory vasculitis of
unknown etiology that occurs in older persons
and can result in a wide variety of systemic
neurologic and ophthalmilogic complication
• Is the common form of systemic vasculitis in adults
• Etiology:
- The exact etiology is remain unclear
- Genetic, environment and autoimmune factors
have been identified
• A close relationship exist between GCA and
polymyalgia rheumatica
• About 50 % of patient with GCA have underlying
polymyalgia rheumatica
• 15% of individual with polymyalgia rheumatica
develop GCA
• The precise nature of the association is poorly
understood
Clinical Presentation
• Physical examination
• Blood test : - Erythrocyte sedimentation rate
- CRP
• Biopsy
• MRI
• PET scan
Red Flags for Secondary Headache
• Systemic symptoms including fever
• Neoplasm history
• Neurologic deficit (including derceased
consciousness)
• Sudden or abrupt onset
• Older age (after 65 years)
• Pattern change or recent onset of new
headache)
Red Flags for Secondary Headache
• Positional headache
• Precipitate by sneezing, coughing or exercise
• Papiledema
• Progressive headache and atypical
presentations
• Pregnancy or puerperium
Red Flags for Secondary Headache